WHO-GMP Certified Facility

Instagram Facebook-f Linkedin
icon

WHO-GMP Certified Facility

Inquire Now

(R)-2-(2-Aminothiazol-4-yl)-N-(2-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide

CPPL / Product / (R)-2-(2-Aminothiazol-4-yl)-N-(2-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide

(R)-2-(2-Aminothiazol-4-yl)-N-(2-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide

(R)-2-(2-Aminothiazol-4-yl)-N-(2-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide is a structurally related compound associated with Mirabegron and is also identified in chemical references as ortho-Mirabegron.

This compound may be relevant to pharmaceutical process research, analytical evaluation, and impurity-related investigations, depending on the intended grade and validated use. Its identity and quality should be established through appropriate analytical characterization and batch documentation.

Description:

(R)-2-(2-Aminothiazol-4-yl)-N-(2-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide is a structurally related compound associated with Mirabegron and is also identified in chemical references as ortho-Mirabegron.

Applications

  • Pharmaceutical research associated with Mirabegron-related compounds.
  • Analytical method development and compound characterization.
  • Impurity profiling and quality-control investigations, where appropriate.
  • Process development and evaluation of related chemical structures.
  • Specialty chemical sourcing for qualified pharmaceutical customers.

Product Specifications

  • Consult the current SDS before handling the material.
  • Use suitable gloves, protective clothing, and eye protection.
  • Avoid generating or inhaling dust.
  • Prevent unnecessary skin and eye contact.
  • Handle in an appropriately ventilated laboratory or industrial area.
  • Keep the product in its designated, labelled container.
  • Follow approved procedures for spills, waste disposal, storage, and transport.

Mechanism of Actions

The compound is not the same as the marketed Mirabegron API. Its presence in a chemical reference database does not establish that it is an approved medicine or that it has the same therapeutic activity.

Mirabegron acts as a beta-3 adrenergic receptor agonist, promoting relaxation of the detrusor muscle during bladder filling. A separate, clinically established therapeutic mechanism should not be attributed to this related compound without appropriate evidence.

FAQs

1. What is CAS 1684452-80-9?

It identifies a Mirabegron-related compound known as ortho-Mirabegron in chemical reference sources.

2. What is its molecular formula?

The molecular formula is C21H24N4O2S.

3. What is its molecular weight?

Its molecular weight is approximately 396.51 g/mol.

4. Is this compound identical to Mirabegron?

No. It is a distinct chemical structure and should not be treated as interchangeable with the approved Mirabegron API.

5. What are its potential applications?

Potential applications include pharmaceutical research, analytical characterization, and impurity-related investigations, depending on the material’s intended grade and supporting documentation.

6. Can I request a sample or technical documents?

Contact Chemox Pharma to confirm availability, sample quantities, analytical documentation, and applicable supply conditions.

Related Products
Request Sample